We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
401
Macerich
MAC
$6.63B
| $319K | 0.01% |
20,000
| – | – |
2021 Q4
8 quarters
|
|
402
LSI Industries
LYTS
$726M
| $317K | 0.01% |
22,256
| – | – |
2021 Q4
8 quarters
|
|
403
Tractor Supply
TSCO
$17.1B
| $315K | 0.01% |
7,300
+280
| +4% | +$11.4K |
2022 Q1
7 quarters
|
|
404
InfraCap MLP ETF
AMZA
$467M
| $311K | 0.01% |
8,850
| – | – |
2023 Q2
2 quarters
|
|
405
EA Bridgeway Omni Small-Cap Value ETF
BSVO
$2.42B
| $309K | 0.01% |
+14,455
| New | +$272K |
2023 Q4
0 quarters
|
|
406
Arista Networks
ANET
$229B
| $308K | 0.01% |
5,200
| – | – |
2022 Q1
7 quarters
|
|
407
PVH
PVH
$3.97B
| $308K | 0.01% |
2,500
-215
| -8% | -$19.2K |
2023 Q2
2 quarters
|
|
408
Choice Hotels
CHH
$5.07B
| $305K | 0.01% |
2,700
| – | – |
2021 Q4
8 quarters
|
|
409
Regeneron Pharmaceuticals
REGN
$82.2B
| $303K | ﹤0.01% |
344
| – | – |
2017 Q1
27 quarters
|
|
410
Steris
STE
$21.8B
| $303K | ﹤0.01% |
1,367
+1,000
| +272% | +$211K |
2022 Q1
7 quarters
|
|
411
U.S. Core Equity 2 Portfolio ETF Class Shares
DFAC
$49.2B
| $301K | ﹤0.01% |
10,255
+4,007
| +64% | +$108K |
2021 Q2
10 quarters
|
|
412
NXP Semiconductors
NXPI
$60.3B
| $299K | ﹤0.01% |
1,290
| – | – |
2015 Q1
35 quarters
|
|
413
Brookfield
BN
$83.4B
| $297K | ﹤0.01% |
11,087
+416
| +4% | +$9.44K |
2013 Q2
42 quarters
|
|
414
iShares Core Dividend Growth ETF
DGRO
$44.1B
| $296K | ﹤0.01% |
5,484
-575
| -9% | -$29.2K |
2021 Q1
11 quarters
|
|
415
Fastenal
FAST
$59.4B
| $296K | ﹤0.01% |
9,120
| – | – |
2019 Q3
17 quarters
|
|
416
Takeda Pharmaceutical
TAK
$64B
| $296K | ﹤0.01% |
20,781
| – | – |
2021 Q4
8 quarters
|
|
417
Oneok
OKE
$58.4B
| $295K | ﹤0.01% |
4,180
+198
| +5% | +$13.3K |
2023 Q3
1 quarter
|
|
418
iShares ESG Advanced Universal USD Bond ETF
EUSB
$703M
| $293K | ﹤0.01% |
6,762
-1,045
| -13% | -$43.4K |
2022 Q4
4 quarters
|
|
419
Dominion Energy
D
$55.4B
| $287K | ﹤0.01% |
6,106
-500
| -8% | -$22.3K |
2013 Q2
42 quarters
|
|
420
Schwab Short-Term US Treasury ETF
SCHO
$15.6B
| $287K | ﹤0.01% |
11,850
+940
| +9% | +$22.6K |
2019 Q3
17 quarters
|
|
421
iShares ESG Optimized MSCI USA ETF
SUSA
$4.08B
| $284K | ﹤0.01% |
2,820
| – | – |
2016 Q2
30 quarters
|
|
422
State Street SPDR S&P Biotech ETF
XBI
$10.6B
| $283K | ﹤0.01% |
3,120
| – | – |
2013 Q2
42 quarters
|
|
423
Gilead Sciences
GILD
$193B
| $281K | ﹤0.01% |
3,466
-800
| -19% | -$62.3K |
2014 Q1
39 quarters
|
|
424
Progressive
PGR
$128B
| $279K | ﹤0.01% |
1,760
-630
| -26% | -$98.6K |
2022 Q1
7 quarters
|
|
425
Liberty Live Group Series C
LLYVK
$9.2B
| $276K | ﹤0.01% |
7,375
| – | – |
2023 Q3
1 quarter
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.